Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 8781740, 8 pages
http://dx.doi.org/10.1155/2016/8781740
Clinical Study

The Effect of Immunonutrition on the Postoperative Complications in Thymoma with Myasthenia Gravis

1Department of Thoracic Surgery, The First Hospital of Jilin University, 71 Xinmin Street, Changchun 130021, China
2Institute for the Control of Agrochemicals, Ministry of Agriculture, Beijing 100125, China

Received 30 August 2016; Revised 11 October 2016; Accepted 20 October 2016

Academic Editor: Jie Yin

Copyright © 2016 Yanzhong Xin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Fujii, “Thymus, thymoma and myasthenia gravis,” Surgery Today, vol. 43, no. 5, pp. 461–466, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Y.-J. Qu, G.-B. Liu, H.-S. Shi, M.-Y. Liao, G.-F. Yang, and Z.-X. Tian, “Preoperative CT findings of thymoma are correlated with postoperative Masaoka clinical stage,” Academic Radiology, vol. 20, no. 1, pp. 66–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. G. O. Skeie, S. Apostolski, A. Evoli et al., “Guidelines for treatment of autoimmune neuromuscular transmission disorders,” European Journal of Neurology, vol. 17, no. 7, pp. 893–902, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Davenport and R. A. Malthaner, “The role of surgery in the management of thymoma: a systematic review,” Annals of Thoracic Surgery, vol. 86, no. 2, pp. 673–684, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. C. B. Falkson, A. Bezjak, G. Darling et al., “The management of thymoma: a systematic review and practice guideline,” Journal of Thoracic Oncology, vol. 4, no. 7, pp. 911–919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Detterbeck, S. Youssef, E. Ruffini, and M. Okumura, “A review of prognostic factors in thymic Malignancies,” Zhongguo Fei Ai Za Zhi, vol. 17, no. 2, pp. 130–136, 2014. View at Google Scholar
  7. T. Murakawa, J. Nakajima, T. Kohno et al., “Results from surgical treatment for thymoma. 43 years of experience,” The Japanese Journal of Thoracic and Cardiovascular Surgery, vol. 48, no. 2, pp. 89–95, 2000. View at Publisher · View at Google Scholar
  8. J. Kas, D. Kiss, V. Simon, E. Svastics, L. Major, and A. Szobor, “Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies,” Annals of Thoracic Surgery, vol. 72, no. 5, pp. 1691–1697, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Shelly, N. Agmon-Levin, A. Altman, and Y. Shoenfeld, “Thymoma and autoimmunity,” Cellular and Molecular Immunology, vol. 8, no. 3, pp. 199–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Lindner, B. Schalke, and K. V. Toyka, “Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients,” Journal of Neurology, vol. 244, no. 8, pp. 515–520, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Beekman, J. B. M. Kuks, and H. J. G. H. Oosterhuis, “Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients,” Journal of Neurology, vol. 244, no. 2, pp. 112–118, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. Amato and J. A. Russell, “Disorders of neuromuscular transmission,” in Neuromuscular Disorders, A. A. Amato and J. A. Russell, Eds., pp. 457–528, McGraw-Hill Medical, New York, NY, USA, 2008. View at Google Scholar
  13. Y. Wu, Y. Chen, H. Liu, and S. Zou, “Risk factors for developing postthymectomy myasthenic crisis in Thymoma Patients,” Journal of Cancer Research and Therapeutics, vol. 11, no. 5, pp. C115–C117, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. S. J. Darnton, B. Zgainski, I. Grenier et al., “The use of an anabolic steroid (nandrolone decanoate) to improve nutritional status after esophageal resection for carcinoma,” Diseases of the Esophagus, vol. 12, no. 4, pp. 283–288, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Aiko, Y. Yoshizumi, Y. Sugiura et al., “Beneficial effects of immediate enteral nutrition after esophageal cancer surgery,” Surgery Today, vol. 31, no. 11, pp. 971–978, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kano, Y. Nabeya, Y. Akutsu, K. Shuto, M. Uesato, and Y. Miyazawa, “Effect of practical use of preoperative immunonutrition with impact on prevention of postoperative pneumonia after esophagectomy,” Gan To Kagaku Ryoho, vol. 36, no. 12, pp. 1958–1960, 2009. View at Google Scholar
  17. L. Marano, R. Porfidia, M. Pezzella et al., “Clinical and immunological impact of early postoperative enteral immunonutrition after total gastrectomy in gastric cancer patients: a prospective randomized study,” Annals of Surgical Oncology, vol. 20, no. 12, pp. 3912–3918, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Giger, M. Büchler, J. Farhadi et al., “Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study,” Annals of Surgical Oncology, vol. 14, no. 10, pp. 2798–2806, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. I. T. D. Correia and D. L. Waitzberg, “The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis,” Clinical Nutrition, vol. 22, no. 3, pp. 235–239, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Gianotti, M. Braga, L. Nespoli, G. Radaelli, A. Beneduce, and V. Di Carlo, “A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer,” Gastroenterology, vol. 122, no. 7, pp. 1763–1770, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Gajdos, S. Chevret, and K. V. Toyka, “Intravenous immunoglobulin for myasthenia gravis,” Cochrane Database of Systematic Reviews, vol. 12, Article ID CD002277, 2012. View at Google Scholar · View at Scopus
  22. F. Eftimov, J. B. Winer, M. Vermeulen, R. de Haan, and I. N. van Schaik, “Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy,” The Cochrane Database of Systematic Reviews, no. 12, Article ID CD001797, 2013. View at Google Scholar · View at Scopus
  23. L. H. Phillips II, “The epidemiology of myasthenia gravis,” Annals of the New York Academy of Sciences, vol. 998, pp. 407–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Panda, V. Goyal, M. Behari, S. Singh, and T. Srivastava, “Myasthenic crisis: A Retrospective Study,” Neurology India, vol. 52, no. 4, pp. 453–456, 2004. View at Google Scholar · View at Scopus
  25. M. E. Fink, “Treatment of the critically ill patient with myasthenia gravis,” in Neurological and Neurosurgical Intensive Care, A. H. Ropper, Ed., pp. 351–362, Raven Press, New York, NY, USA, 3rd edition, 2016. View at Google Scholar
  26. A. Soleimani, A. Moayyeri, S. Akhondzadeh, M. Sadatsafavi, H. T. Shalmani, and A. Soltanzadeh, “Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: a 17-year experience,” BMC Neurology, vol. 4, article 12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Faist, T. S. Kupper, C. C. Baker, I. H. Chaudry, J. Dwyer, and A. E. Baue, “Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation,” Archives of Surgery, vol. 121, no. 9, pp. 1000–1005, 1986. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Braga, L. Gianotti, A. Vignali, and V. D. Carlo, “Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer,” Surgery, vol. 132, no. 5, pp. 805–814, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Braga, L. Gianotti, A. Vignali, and V. Di Carlo, “Immunonutrition in gastric cancer surgical patients,” Nutrition, vol. 14, no. 11-12, pp. 831–835, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Tang, J. Li, F. Li et al., “Autophagy protects intestinal epithelial cells against Deoxynivalenol toxicity by alleviating oxidative stress via IKK signaling pathway,” Free Radical Biology and Medicine, vol. 89, pp. 944–951, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Sivaprakasam, A. Gurav, A. V. Paschall et al., “An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis,” Oncogenesis, vol. 5, no. 6, article e238, 2016. View at Publisher · View at Google Scholar
  32. N. R. Rowan, J. T. Johnson, C. E. Fratangelo, B. K. Smith, P. A. Kemerer, and R. L. Ferris, “Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients,” Oral Oncology, vol. 54, pp. 42–46, 2016. View at Publisher · View at Google Scholar
  33. P. Moya, L. Soriano-Irigaray, J. M. Ramirez et al., “Perioperative standard oral nutrition supplements versus immunonutrition in patients undergoing colorectal resection in an enhanced recovery (ERAS) protocol,” Medicine, vol. 95, no. 21, Article ID e3704, 2016. View at Publisher · View at Google Scholar
  34. S. Silvestri, A. Franchello, G. Deiro et al., “Preoperative oral immunonutrition versus standard preoperative oral diet in well nourished patients undergoing pancreaticoduodenectomy,” International Journal of Surgery, vol. 31, pp. 93–99, 2016. View at Publisher · View at Google Scholar
  35. C. Mariette, “Immunonutrition,” Journal of Visceral Surgery, vol. 152, supplement 1, pp. S14–S17, 2015. View at Publisher · View at Google Scholar
  36. G. M. Song, X. Tian, H. Liang et al., “Role of enteral immunonutrition in patients undergoing surgery for gastric cancer: a systematic review and meta-analysis of randomized controlled trials,” Medicine, vol. 94, no. 31, p. e1311, 2015. View at Publisher · View at Google Scholar
  37. A. A. Rabinstein and N. Mueller-Kronast, “Risk of extubation failure in patients with myasthenic crisis,” Neurocritical Care, vol. 3, no. 3, pp. 213–215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Shimogawa, T. Morioka, N. Hagiwara, T. Akiyama, T. Sayama, and S. Haga, “Infection control effect of dietary fluid with whey peptide in the management of patients with severe intracranial hemorrhage during the acute stage,” Fukuoka Igaku Zasshi, vol. 106, no. 11, pp. 302–307, 2015. View at Google Scholar
  39. S. Beloribi-Djefaflia, S. Vasseur, and F. Guillaumond, “Lipid metabolic reprogramming in cancer cells,” Oncogenesis, vol. 5, no. 1, article e189, 2016. View at Publisher · View at Google Scholar
  40. P. C. Calder, “Fatty acids and inflammation from the membrane to thenucleus and from the laboratory bench to the clinic,” Clinical Nutrition, vol. 29, no. 1, pp. 5–12, 2010. View at Publisher · View at Google Scholar
  41. M. C. Tossou, H. Liu, M. Bai et al., “Effect of high dietary tryptophan on intestinal morphology and tight junction protein of weaned pig,” BioMed Research International, vol. 2016, Article ID 2912418, 6 pages, 2016. View at Publisher · View at Google Scholar
  42. G. Gstraunthaler, F. Landauer, and W. Pfaller, “Ammoniagenesis in LLC-PK1 cultures: role of transamination,” American Journal of Physiology-Cell Physiology, vol. 263, no. 1, pp. C47–C54, 1992. View at Google Scholar · View at Scopus
  43. P. E. Wischmeyer, “Glutamine: mode of action in critical illness,” Critical Care Medicine, vol. 35, no. 9, pp. S541–S544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. J. M. Rhoads, R. A. Argenzio, W. Chen et al., “L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 272, no. 5, pp. G943–G953, 1997. View at Google Scholar · View at Scopus
  45. A. Barbul, S. A. Lazarou, D. T. Efron, H. L. Wasserkrug, and G. Efron, “Arginine enhances wound healing and lymphocyte immune responses in humans,” Surgery, vol. 108, no. 2, pp. 331–337, 1990. View at Google Scholar · View at Scopus
  46. Y. Gunerhan, N. Koksal, U. Y. Sahin, M. A. Uzun, and E. Ekşioglu-Demiralp, “Effect of preoperative immunonutrition and other nutrition models on cellular immune parameters,” World Journal of Gastroenterology, vol. 15, no. 4, pp. 467–472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Xu, Y. Zhong, D. Jing, and Z. Wu, “Preoperative enteral immunonutrition improves postoperative outcome in patients with gastrointestinal cancer,” World Journal of Surgery, vol. 30, no. 7, pp. 1284–1289, 2006. View at Publisher · View at Google Scholar · View at Scopus